2021
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators
Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, Casanovas-Massana A, Minasyan M, Farhadian S, Ko AI, Team Y, Dela Cruz CS, Bosio CM. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. The Journal Of Immunology 2021, 206: ji2001025. PMID: 33277388, PMCID: PMC7962598, DOI: 10.4049/jimmunol.2001025.Peer-Reviewed Original ResearchConceptsLipid mediatorsRisk factorsSevere diseaseSevere SARS-CoV-2 infectionHospitalized COVID-19 patientsSARS-CoV-2 infectionImportant immune regulatory roleSevere COVID-19COVID-19 patientsImmune regulatory roleProinflammatory lipid mediatorsCOVID-19Immunomodulatory eicosanoidsImmune mediatorsSerum lipidomeAdvanced agePatientsCOVID-19 pandemicCytochrome P450MortalityDiseaseDysregulationMediatorsLMS productsLipidome
2020
Does inflammation help during COVID-19?
Sharma L, Chang D, Dela Cruz CS. Does inflammation help during COVID-19? ERJ Open Research 2020, 6: 00557-2020. PMID: 33083436, PMCID: PMC7553107, DOI: 10.1183/23120541.00557-2020.Peer-Reviewed Original Research
2018
Personalizing the Management of Pneumonia
Gautam S, Sharma L, Dela Cruz CS. Personalizing the Management of Pneumonia. Clinics In Chest Medicine 2018, 39: 871-900. PMID: 30390755, DOI: 10.1016/j.ccm.2018.08.008.Books
2016
Atypical Pneumonia Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia
Sharma L, Losier A, Tolbert T, Dela Cruz CS, Marion CR. Atypical Pneumonia Updates on Legionella, Chlamydophila, and Mycoplasma Pneumonia. Clinics In Chest Medicine 2016, 38: 45-58. PMID: 28159161, PMCID: PMC5679202, DOI: 10.1016/j.ccm.2016.11.011.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements